MOSCOW (Reuters) – Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia’s Sputnik V COVID-19 vaccine annually, the Russian Direct Investment Fund (RDIF), which markets the shot internationally, said on Monday.
RDIF did not say when production would begin.
(Reporting by Vladimir Soldatkin; Writing by Alexander Marrow, ediitng by Emelia Sithole-Matarise)
Bruins-Panthers getting set for Game 2. Canucks-Oilers ready to open their series
Joe Burrow is throwing again as the Bengals’ franchise QB rehabs his surgically repaired wrist
PGA Championship invites 7 LIV players to get top 100 in the world
A jury awards $9 million to a player who sued the US Tennis Association over sexual abuse by a coach
CFL’s Chad Kelly suspended at least 9 games after investigation into ex-coach’s lawsuit
Scenes from Israel and Gaza reflect dashed hopes as imminent cease-fire seems unlikely
Louisiana lawmakers reject adding exceptions of rape and incest to abortion ban
More and faster: Electricity from clean sources reaches 30% of global total
Biden hosts Romanian leader at the White House to celebrate NATO partnership
3 pedestrians hurt in Kensington hit-and-run crash
